NCT04909294View on ClinicalTrials.gov

Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2030

Conditions
Adenocarcinoma of the Prostate
Interventions
RADIATION

Stereotactic Radiotherapy with Linac MRI

"38 Gy in 4 fractions of 9.5 Gy over the entire prostate,~+/- 2 Gy in 4 fractions of 0.5 Gy as an integrated boost on the index tumor if it is visible on diagnostic multiparametric MRI (PIRADS-V2 score 4 or 5) and on planning MRI performed on Linac MRI."

Trial Locations (1)

21000

Centre Georges François Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER